Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus (Q43174291)
Jump to navigation
Jump to search
scientific article published on 4 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus |
scientific article published on 4 February 2010 |
Statements
1 reference
Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus (English)
1 reference
I Kanazawa
1 reference
T Yamaguchi
1 reference
S Yano
1 reference
M Yamamoto
1 reference
M Yamauchi
1 reference
S Kurioka
1 reference
T Sugimoto
1 reference
4 February 2010
1 reference
1 reference
21
1 reference
12
1 reference
2013-2018
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference